SELINEXOR

SELINEXOR (13086R)

selinexor 20 mg tablet, 20
13086R
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment - Dose requirement of 100 mg per week

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment - Dose requirement of 100 mg per week
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 20 # of repeats: 2 DPMQ: $11,700.00 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Xpovio

SELINEXOR (13103P)

selinexor 20 mg tablet, 20
13103P
Body System:
Manner of administration:Oral
Private
S100 HSD Private
Authority Required

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment - Dose requirement of 100 mg per week

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment - Dose requirement of 100 mg per week
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 20 # of repeats: 2 DPMQ: $11,748.88 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Xpovio